Amber Cramer

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A scalable, GMP-compatible, autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa”.

A scalable, GMP-compatible, autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.28.529447

N/A

0DataRank · unranked

10 citations

Jessica L. Torkelson, Shengdi Li, Kelly McCarthy, Hanson H. Zhen, Madhuri Vangipuram +22 more

A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa

Nature Communications(2024)10.1038/s41467-024-49400-z

N/A

0DataRank · unranked

18 citations

Jessica L. Torkelson, Shengdi Li, Kelly McCarthy, Hanson H. Zhen, Madhuri Vangipuram +26 more

A Massively Parallel CRISPR-Based Screening Platform for Modifiers of Neuronal Activity

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.28.582546

N/A

0DataRank · unranked

6 citations

Vaidehi Gandhi, Ming‐Chi Tsai, Emily Marzette, Noam Teyssier, Joanna Yu-Ying Chou +10 more